OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded Contract SPE2DP26F6392 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the provision of OMEPRAZOLE EXTENDED with NSN 6505013142716. This award is issued under the vehicle SPE2DX25D9900 and was officially posted on July 23, 2026, with an award date of June 5, 2026. The total contract value is specified in the award documentation, though the exact amount is not disclosed here. The procurement is for federal use, managed by the Department of Defense, and no set-aside preferences or NAICS codes are indicated. Performance is expected to support DLA operations across the United States, with no specific city or state designated for delivery. All technical and logistical details are tied to the single line item for OMEPRAZOLE EXTENDED, and direct inquiries or documentation access can be obtained through the official DIBBS award link.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
